B, L., YC, K., MR, S., ATH, W., & HS, H. (2021). In vivo Pharmacokinetic and Anticancer Studies of HH-N25, a Selective Inhibitor of Topoisomerase I, and Hormonal Signaling for Treating Breast Cancer. Dove Medical Press.
Style de citation Chicago (17e éd.)B, Lawal, Kuo YC, Sumitra MR, Wu ATH, et Huang HS. In Vivo Pharmacokinetic and Anticancer Studies of HH-N25, a Selective Inhibitor of Topoisomerase I, and Hormonal Signaling for Treating Breast Cancer. Dove Medical Press, 2021.
Style de citation MLA (8e éd.)B, Lawal, et al. In Vivo Pharmacokinetic and Anticancer Studies of HH-N25, a Selective Inhibitor of Topoisomerase I, and Hormonal Signaling for Treating Breast Cancer. Dove Medical Press, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.